Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone versus intramuscular progesterone for luteal phase support in IVF
IRCT20200421047152N5Phase 3Completed
- Sponsor
- ACECR
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in infertility comparing Dydrogesterone receiving group with Intramuscular progesterone receiving group (2 arms). Primary endpoints: Clinical pregnancy, Chemical pregnancy and 1 more. Started Nov 2023; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20200421047152N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200421047152N5.